The COVID Reckoning Doesn't Go Far Enough
The COVID-19 pandemic exposed the failures of the US public health establishment, but true reform requires dismantling the FDA's monopoly on drug approval. The FDA's power has been expanding since the 1962 Kefauver-Harris Amendments, which allowed it to regulate drugs based on both safety and efficacy.
The US public health establishment lost trust during the COVID-19 pandemic due to bureaucratic incompetence and authoritarian mandates. The Food and Drug Administration (FDA) has the worst track record, slowing down drug development and causing hundreds of thousands of lost life years. The FDA's power expanded with the 1962 Kefauver-Harris Amendments, allowing it to regulate drugs based on both safety and efficacy. Prior to this, drug makers decided whether to require a doctor's prescription based on liability concerns. To fix America's regulatory healthcare apparatus, the FDA's monopoly must be dismantled. Real medical freedom requires more than just replacing the public health establishment.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.